1. EFFECTS OF A PROGESTOGEN ON NORMAL HUMAN BREAST EPITHELIAL CELL APOPTOSIS IN VITRO AND IN VIVO
- Author
-
J.-L. Thomas, Joëlle Desreux, Alfred Bernard, Agnès Noël, J.-M. Foidart, Karine Peyrollier, F. Kebers, J. Paris, and R. Delansorne
- Subjects
Programmed cell death ,medicine.drug_class ,business.industry ,Obstetrics and Gynecology ,Hyperplasia ,Luteal phase ,medicine.disease ,Fibroadenoma ,Breast cancer ,Oncology ,Apoptosis ,In vivo ,Cancer research ,medicine ,skin and connective tissue diseases ,business ,Progestin - Abstract
SUMMARY. Many investigators have reported cyclic proliferation of normal human breast epithelial cells. A delicate balance between proliferation and apoptosis (programmed cell death) ensures breast homeostasis. Both the follicular and luteal phases of the menstrual cycle are characterized by proliferation, whereas apoptosis occurs only at the end of the latter phase. In this study, we observed that the withdrawal of a synthetic progestin (nomegestrol acetate or NOMAC), but not continuous treatment with it, induced apoptosis of normal human breast epithelial cells in vitro and in women who applied NOMAC gel to their breasts. Furthermore, this apoptotic response was specific to normal breast cells, since withdrawal of NOMAC did not induce apoptosis of tumoral T47D cells in vitro or of fibroadenoma cells in women. These observations open up new perspectives in the prevention of hyperplasia and breast cancer. r 2003 Elsevier Science Ltd. All rights reserved.
- Published
- 2003
- Full Text
- View/download PDF